Previous Close | 19.83 |
Open | 20.45 |
Bid | 0.00 |
Ask | 0.00 |
Strike | 200.00 |
Expire Date | 2024-06-21 |
Day's Range | 19.83 - 20.45 |
Contract Range | N/A |
Volume | |
Open Interest | N/A |
Hologic's (HOLX) GYN Surgical Q2 performance was driven by strong results from MyoSure and Fluent Fluid Management.
Lantheus' (LNTH) robust revenues from the majority of its segments drive its first-quarter performance.
Bruker's (BRKR) BioSpin segment witnessed growth across biopharma, academic government and industrial research in the first quarter of 2024.